TSC Clinical Trial
— TRAINOfficial title:
TSC Remote Assessment and Intervention
The investigators propose a study to adapt an evidence-based caregiver training program to improve access in order to better serve the TSC community. The proposed adapted caregiver training program is based on a targeted behavioral intervention called JASPER (Joint attention, symbolic play, engagement, and regulation) that has successfully improved outcomes in children with ASD. Importantly, JASPER specifically targets two key developmental domains known to be critical for young children with TSC, social communication and play. Recent work with JASPER in children with TSC shows promise, but still requires a commitment to regular in-person sessions. The investigators hope to test an adapted version of the caregiver training version of JASPER, where the entire training is provided remotely through weekly teleconferences and video feedback. The investigators goal is to determine if remote caregiver training can improve social engagement and communication between caregivers and their child with TSC. The investigators hope that by adapting the caregiver training version of JASPER to be delivered through telehealth methods, the investigators can help more families gain access to high quality training. There is a tremendous need for high quality early intervention, and remote caregiver training can give families the skills they need to make impactful and lasting improvements for their child with TSC. The investigators will recruit 66 children, 22 per year whom have been clinically diagnosed with TSC, are 12-36 months of age, English as primary language at home, and have one parent available for weekly remote video conferencing. Participants that meet criteria will be asked to complete assessments from their home (kits will be mailed to them), which will take several sessions (approximately 2.5 hours). During these assessment sessions via Zoom, participants will be shown how to do BOSA, SPACE and CCX assessments. A Vineland and Ages and Stages Questionnaire will also be done during these sessions, but it's just questionnaires. The SPACE and CCX are particulary important because the participants will have to record themselves throughout the study doing these assessments. A brief introduction to JASPER will also be given during this period of assessments. Randomization will occur after assessments are complete. Participants randomized to intervention will need to meet with the research staff for 12 weeks via Zoom to discuss their recorded sessions. Each participant in the intervention group is expected to submit (via UCLA Box) a 30-40 minute video doing JASPER with their child. These videos will be discussed during the Zoom calls. The group not randomized to intervention, will continue to care for their child as usual for those 12 weeks. They will not need to record or meet via Zoom with the research staff. At the end of the 12 weeks, all participants will record themselves doing the two assessments that were taught at UCLA. They will do and record these assessments again 12 weeks after that in the 3-month follow up. The total study is for 6 months.
Status | Recruiting |
Enrollment | 66 |
Est. completion date | August 30, 2024 |
Est. primary completion date | May 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 12 Months to 36 Months |
Eligibility | Inclusion Criteria: - Confirmed clinical diagnosis of TSC - Chronological age of 12--36 months - English as primary language at home - Have a parent available for weekly remote video conferencing - Scores of 22.5 Gross Motor and 25.14 Fine Motor on the Ages and Stages Questionnaire (ASQ). Exclusion Criteria: - Plan for epilepsy surgery during study period |
Country | Name | City | State |
---|---|---|---|
United States | UCLA Semel Institute | Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Los Angeles |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Brief Observation of Symptoms of Autism (BOSA) | It is a measure that detects the presence or absence of autism symptoms. | entry (1st month of study) | |
Other | Ages and Stages Questionnaire | It measures change in the child's cognitive level throughout the study. | screening, entry (1st month of study), exit (month 3 of the study), follow up (month 6 of the study) | |
Other | Vineland Adaptive Behavior Scale Third Edition (VABS-III) | An adaptive behavior assessment. The Adaptive Behavior Composite (ABC) of the VABS-III has a standard score mean of 100 and standard deviation (SD) of 15. Higher scores signifying a better outcome. The Vineland will measure the child's adaptive behavior throughout the study. | entry (1st month of study), exit (month 3 of the study), follow up (month 6 of the study) | |
Other | Demographic and Medical Questionnaire | Descriptive measure to determine child's eligibility. | entry (1st month of study) | |
Primary | Change in Caregiver-Child Interaction (CCX)-joint engagement | The child is jointly engaged with the caregiver in recorded play interactions. A change from entry (1st month of study) to exit (month 3 of study) will be assessed and exit (3 month of study) to follow up (month 6) as well as entry to follow up (month 6) will be assessed. | entry (1st month of study), exit (month 3 of the study), follow up (month 6 of the study) | |
Primary | Change in Short Play and Communication Evaluation (SPACE)- joint engagement | The child is jointly engaged with the caregiver in recorded play interactions. A change from entry (1st month of study) to exit (month 3 of study) will be assessed and exit (3 month of study) to follow up (month 6) as well as entry to follow up (month 6) will be assessed. | entry (1st month of study), exit (month 3 of the study), follow up (month 6 of the study) | |
Secondary | Short Play and Communication Evaluation (SPACE)- Joint attention | The child is initiating social communication with the caregiver in recorded assessments. | entry (1st month of study), exit (month 3 of the study), follow up (month 6 of the study) | |
Secondary | Short Play and Communication Evaluation (SPACE)- Play | The child is initiating play acts that are characterized by developmental level in recorded assessments. | entry (1st month of study), exit (month 3 of the study), follow up (month 6 of the study) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03649919 -
Multi-center Clinical Study on the Diagnosis and Treatment Management of Rare Neurological Disease in Children
|
||
Recruiting |
NCT02098759 -
Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis Complex
|
N/A | |
Active, not recruiting |
NCT05103358 -
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
|
Phase 2 | |
Recruiting |
NCT06105736 -
Regulating Together in Tuberous Sclerosis Complex
|
N/A |